Immunome (IMNM) Asset Utilization Ratio (2023 - 2026)
Immunome (IMNM) reported Asset Utilization Ratio of 0.01 for Q1 2026, down 83.58% on a YoY basis from 0.04 in Q1 2025, and down 56.38% quarter-over-quarter from 0.01 in Q4 2025.
Immunome (IMNM) Asset Utilization Ratio (2023 - 2026) Analysis & Trends
Immunome has reported Asset Utilization Ratio for 4 years, with the latest figure at 0.01 in Q1 2026.
- For the quarter ending Q1 2026, Asset Utilization Ratio fell 83.58% year-over-year to 0.01; the trailing twelve-month figure through Mar 2026 stood at 0.01 (down 83.58% YoY), and the FY2025 full-year result was 0.02, down 67.68% from the prior year.
- Asset Utilization Ratio for Q1 2026 stood at 0.01, down from 0.01 in the prior quarter.
- The five-year high for Asset Utilization Ratio was 0.12 in Q4 2023, with the low at 0.01 in Q1 2026.
- Historically, Asset Utilization Ratio has averaged 0.04 across 4 years, with a median of 0.04 in 2024.
- Annual changes were most pronounced in 2025 — Asset Utilization Ratio grew 12.53% — and 2026, when it plunged 83.58%.
- Immunome's Asset Utilization Ratio stood at 0.12 in 2023, then slumped by 68.64% to 0.04 in 2024, then sank by 61.16% to 0.01 in 2025, then plunged by 56.38% to 0.01 in 2026.
- The last three Asset Utilization Ratio figures came in at 0.01 (Q1 2026), 0.01 (Q4 2025), and 0.03 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 0.55 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 0.60 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 1,422.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 0.47 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Immunome | 2.12 Bn | 1.54 Bn | - | 0.01 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.01 |
| Dec 31, 2025 | 0.01 |
| Sep 30, 2025 | 0.03 |
| Jun 30, 2025 | 0.04 |
| Mar 31, 2025 | 0.04 |
| Dec 31, 2024 | 0.04 |
| Sep 30, 2024 | 0.04 |
| Jun 30, 2024 | 0.04 |
| Mar 31, 2024 | 0.05 |
| Dec 31, 2023 | 0.12 |